All In MedTech

Device Trial Radar · NCT02593149

Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap

Last checked: Nov 20, 2026Latest source record: Feb 27, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,902 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,902

Actual

Start

Nov 2015

Primary completion

Nov 2016

Study completion Nov 2016

Sponsor

Lead sponsor
Pursuit Vascular, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Davita Clinical Research
First posted
Oct 30, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess blood stream infections in participants using two FDA-cleared devices: ClearGuard HD end caps compared to the Tego® connector with the CurosTM for Tego disinfecting port protector.

Conditions

  • End Stage Renal Disease (ESRD)

Interventions

  • ClearGuard HD End CapDevice

    The ClearGuard HD end cap elutes chlorhexidine acetate into the hemodialysis hub

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Positive Blood Cultures (PBC's) Per 1,000 Central Venous Catheter (CVC)-DaysTime frame: Through the 13-month intervention period.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • DaVita Clinical Research

    Minneapolis, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.